Search research articles
Contact Us
Filters
Showing results (271-280 of 420) with videos related to
Page
of 42
Sort By:
Journal of Clinical Microbiology
|
December 1, 1986
Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods
R N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1985
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies
R N Jones, H W Wilson, C Thornsberry, et al.
Journal of Clinical Microbiology
|
April 1, 1984
Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid
P C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates
P C Fuchs, A L Barry, C Thornsberry, et al.
Reviews of Infectious Diseases
|
September 1, 1982
Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response
C Thornsberry, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
November 1, 1984
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks
A L Barry, C Thornsberry, T L Gavan, et al.
Journal of Clinical Microbiology
|
September 1, 1987
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria
A L Barry, R N Jones, T L Gavan, et al.
Journal of Clinical Microbiology
|
June 1, 1983
Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing
D A Preston, R N Jones, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1985
In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition
R N Jones, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1985
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin
P C Fuchs, R N Jones, A L Barry, et al.
Page
of 42
Search research articles
Search
Showing results (271-280 of 420) with videos related to
Sort By:
Page
of 42
Journal of Clinical Microbiology
|
December 1, 1986
Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods
R N Jones, A L Barry, P C Fuchs, et al.
Diagnostic Microbiology and Infectious Disease
|
November 1, 1985
In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies
R N Jones, H W Wilson, C Thornsberry, et al.
Journal of Clinical Microbiology
|
April 1, 1984
Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid
P C Fuchs, R N Jones, A L Barry, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1984
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates
P C Fuchs, A L Barry, C Thornsberry, et al.
Reviews of Infectious Diseases
|
September 1, 1982
Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response
C Thornsberry, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
November 1, 1984
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks
A L Barry, C Thornsberry, T L Gavan, et al.
Journal of Clinical Microbiology
|
September 1, 1987
Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria
A L Barry, R N Jones, T L Gavan, et al.
Journal of Clinical Microbiology
|
June 1, 1983
Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing
D A Preston, R N Jones, A L Barry, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1985
In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition
R N Jones, A L Barry, P C Fuchs, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 1985
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin
P C Fuchs, R N Jones, A L Barry, et al.
Page
of 42